Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
DOI: 10.1056/NEJM199508313330902 Ferrannini & DeFronzo (2015): Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
11, 2021, article 596130, Steiner, Benjamin M., and Daniel C
In a study in which juvenile dogs received lisdexamfetamine dimesylate for 6 months beginning at 10 weeks of age, decreased bodyweight gain was seen at all doses tested (2, 5, and 12 mg/kg/day, which are approximately 0.5, 1, and 3 times the maximum recommended human daily dose on a mg/m2 basis for a child)
Lowers post-meal glucose and insulin spikes Multiple studies show reductions of 3040% in postprandial glucose levels, especially in meals containing starch or simple carbs
That means better talk between the brain and the GI tract
Tiotropium, marketed under the brand name Spiriva, has been proven to consistently reduce the risk of COPD exacerbations, while providing long-term quality of life benefits and a favourable impact on survival
US$ 29.90
US$ 26.82
US$ 21.40
US$ 23.66
US$ 20.79
